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Background: We describe a case of a fever of unknown etiology that was caused by a caseating tubercle
granuloma which produced erythropoietin. To our knowledge, this is the first report of an erythropoietin-
producing granuloma.
Case presentation: A 48-year-old Japanese man with a 5-year history of maintenance hemodialysis for diabetic
nephropathy presented with an intermittent fever over a few months. During febrile periods he developed erythema
nodosum on his legs. Computed tomography showed axillary lymph node enlargement and this was further
corroborated by a gallium scan that revealed high gallium uptake in these nodes. A Mantoux test was positive and an
interferongamma release assay for tuberculosis diagnosis was also positive. Lymph node tuberculosis was suspected and
the patient underwent lymphadenectomy. Histological analysis of the lymph nodes revealed a caseating granuloma that
showed positive results on an acid-fast bacteria stain and a Mycobacterium tuberculosis polymerase chain reaction test.
After lymphadenectomy, however, the patient’s hemoglobin levels rapidly decreased from 144 to 105 g/L, and this was
further compounded by a decrease in serum erythropoietin from 223 mIU/mL to 10.7 mIU/mL by postoperative day 21.
We suspected the tubercle to be a source of the erythropoietin and this was further confirmed by in situ hybridization.
Conclusions: We report for the first time ectopic erythropoietin production by a tuberculous lymph node. Our
observations are substantiated by a postoperative decline in his erythropoietin level and a clinical requirement for
erythropoietin treatment.
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The complication of polycythemia has been described with
several malignancies, such as renal cell carcinoma, cerebral
meningioma, and hepatocellular carcinoma [1]. In some
cases, ectopic erythropoietin (Epo) production has been
demonstrated in the tumor [2-8]. However, few reports de-
scribe the ectopic production of Epo in benign diseases. Pa-
tients with a benign cystic lesion have been shown to have
increased Epo production [9,10], but Epo has not been
reported as produced ectopically in a lymph node. Here, we
describe a dialysis patient who presented with a fever of un-
known etiology that was caused by a caseating tubercle
granuloma. The caseous tubercle granuloma had produced
Epo that resulted in a maintained hemoglobin level in spite
of dialysis patient with evidence of inflammation. To the* Correspondence: msatoh@med.kawasaki-m.ac.jp
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reproduction in any medium, provided the orbest of our knowledge, this is the first description of an
Epo-producing tubercle granuloma.
Case presentation
A 48-year-old Japanese man with a 5-year history of
maintenance hemodialysis for diabetic nephropathy
presented with spikes of fever every few months accom-
panied by the appearance and regression of multiple
painful subcutaneous nodules over his legs and feet.
These were diagnosed as erythema nodosum by a biopsy
examination. Investigations showed had high levels of
C-reactive protein (150 to 200 mg/L), a hemoglobin level
of 146 g/L, a white blood cell count of 7.0 × 109/L, with
92% neutrophils and a platelet count of 2.2 × 1011/L,
indicating a lack of anemia in spite of chronic inflamma-
tion. Administration of broad-spectrum antibiotics failed
to generate a response. Peripheral lymph nodes were not
palpable. The patient was also found to be negative for
human immunodeficiency virus (HIV) infection. Sputumtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Images of right axillary lymph node tuberculosis.
Images of computed tomography (A) and gallium scanning (B).
(A) Non-enhanced computed tomography scan showing enlarged
right axillary lymph nodes (arrow). (B) Gallium scan showing
abnormal uptake in axillary lymph nodes (arrow).
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and an acid-fast stain test and a Mycobacterium tubercu-
losis polymerase chain reaction (PCR) test were both
negative. Blood and urine cultures were also negative,
and renal ultrasonography did not show renal cysts or
masses. Several tests for collagen disorders including
vasculitis were all negative.
Computed tomography showed axillary lymph node
enlargement (Figure 1A), which was corroborated by a
gallium scan that revealed abnormally high gallium up-
take in the axillary lymph nodes (Figure 1B). When ad-
ministered the Mantoux test, the patient was found to
be purified protein derivative, slightly positive at 10 mm,
which points to tuberculosis infection. Tuberculosis was
further indicated by a positive interferon-gamma release
assay. Chest radiography revealed no abnormal shadowing
in the lung fields, thus ruling out pulmonary tuberculosis.
Based on these results, we suspected lymph node tubercu-
losis, and axillary lymphadenectomy was performed. Six
lymph nodes were surgically removed and their histological
examination revealed caseating granulomata in all of the
lymph nodes (Figure 2A). Langhans giant cells were also
observed in the granuloma. Further, the granuloma tested
positive on an acid-fast bacteria stain (Figure 2B) and a M.
tuberculosis PCR test. He was treated with rifampicin, iso-
niazid, and ethambutol.
To our surprise, lymphadenectomy was followed by a
rapid decline in the patient’s hemoglobin levels from 144
to 105 g/L. Serum Epo levels also decreased from 223
mIU/mL to 10.7 mIU/mL (upper normal limit 23.7 mIU/
mL for normal adult) by postoperative day 21. The patient
received a weekly injection of 40 mg iron sucrose, and his
serum ferritin level was maintained at 50–150 ng/mL. The
patient at this stage needed Epo infusions to maintain
hemoglobin levels (target hemoglobin between 100 and
120 g/L). The strong association between the excision of
the tubercle and the drop in Epo levels made us examine
the granuloma for Epo expression. The tubercle granu-
loma was found to be positive for Epo on in situ
hybridization (Figure 3A). Methods of in situ hybridization
are described in the Additional file 1. We further vali-
dated this by immunohistochemical staining, wherein
strong cytoplasmic staining for Epo was found in these
tubercle granuloma cells. The Epo-producing cells were
positive for CD68 (monocyte/macrophage marker) but
not for CD20 (B lymphocyte marker) or CD8 (cyto-
toxic T lymphocyte marker) (Figure 3B-D).
Conclusions
We present here the first known instance of a tubercle
granuloma implicated in ectopic Epo production. Ectopic
production of a hormone or cytokine by a tumor is well
recognized but not common. Ectopic Epo production
leading to polycythemia has been previously described inassociation with several malignancies [1]. Reports have
demonstrated local existence and production of Epo in
the tumor mass in several different cancer types such as
hepatocellular carcinoma [2,3], renal cell carcinoma [4,5],
gastric carcinoma [6], thymic carcinoma [7], and lung
adenocarcinoma [8].
In our case study, the patient was on chronic mainten-
ance dialysis, and this complicated the diagnosis. Although
A B
Figure 2 Pathological images of tubercle granuloma. Pathological findings (A) and acid-fast bacteria stain (B) of resected axillary lymph node.
(A) Histopathological findings of the resected specimen include caseous necrosis and an epithelioid granuloma with Langhans giant cells (arrow) (PAS
staining, ×100). (B) Microphotograph of the resected axillary lymph node stained with Ziehl-Neelsen stain (×400) showing acid-fast stain-positive bacilli
within the tissue (arrow).
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dialysis are much more susceptible to tuberculosis than the
general population, the diagnosis is often difficult because
of frequent extrapulmonary involvement and nonspecific
symptoms [11]. Extrapulmonary tuberculosis accounts for
approximately 15% to 20% of tuberculosis cases in im-
munocompetent patients [12]. Because tuberculosis is
commonly responsible for fevers of unknown origin [13],
we recommend that a systematic diagnosis approach [14]
be used in the diagnosis of a fever of unknown etiology in




Figure 3 Epo expression in tubercle granuloma. In situ RNA hybridizatio
for CD68 (B), CD20 (C), and CD8 (D). (A) In situ hybridization revealing the
Methods are described in the Additional file 1. Positive signals were observ
observed in the granuloma (arrow) (×200). (C, D) CD20- and CD8-positive csystematic differential diagnosis approach will allow com-
prehensive examination of the patient including an exam-
ination of the lymph nodes and may thus minimize the
possibility of overlooking tuberculosis. Chronic infections
like tuberculosis are usually accompanied by anemia be-
cause of lowered Epo production caused by cytokines such
as tumor necrosis factor [15]. The occurrence of polycy-
themia instead of anemia in a patient with chronic tuber-
culosis is a rare event. In our patient, we believe that the
expected anaemia was avoided because of the Epo overpro-




n of the resected axillary lymph node (A) and immunohistochemistry
expression of Epo mRNA in non-epithelioid cells in lymph nodes.
ed in the granuloma (arrow) (×200). (B) CD68-positive cells were
ells were rarely observed in the granuloma (arrow) (×200).
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hemodialysis, spontaneous erythrocytosis is rare. In rare
cases, hydronephrotic kidney disease [16], obstructive sleep
apnea [17], or renal artery thrombosis [18] can cause
Epo-dependent secondary polycythemia in a dialysis pa-
tient. A high serum Epo level in polycythemic patients sug-
gests secondary erythrocytosis as a possible diagnosis. In
the present case, the hemoglobin data of the patient were
not indicative of erythrocytosis. However, we measured
Epo levels because hemoglobin levels were relatively high
despite the presence of chronic inflammation, which nor-
mally suppresses erythropoiesis. We believe that serum
Epo concentration should be checked to detect any pos-
sible instances of secondary erythrocytosis whenever the
hemoglobin level is disproportionate with the clinical con-
dition. Particularly in cases like ours, where the patient
was on maintenance dialysis, we speculate that the renal
anemia due to chronic dialysis was able to mask the effects
of polycythemia caused by the Epo over-production.
Epo belongs to a family of non-immunological cytokines
[19] and is produced by fibroblasts derived from the
neural crest in renal interstitial spaces [20]. In the present
case, Epo mRNA was observed primarily in the CD68-
positive area of the caseous tubercle granuloma. A previ-
ous report indicated that macrophages can potentially
produce Epo extrarenally [21]. Epo expression is known to
be upregulated by hypoxia through a transcription factor
hypoxia-inducible factor-1 [22]. Other transcription fac-
tors like Wilms tumor protein, Wt1 [23] and GATA-4
[24] are also involved in Epo gene expression in the liver.
So, in this light, although the molecular mechanism
underlying Epo production in macrophages is not known,
it is not an implausible finding.
In conclusion, we report, to the best of our knowledge,
the first case of Epo-producing tubercle granuloma in a
hemodialysis patient. The postoperative clinical exacerba-
tion of anemia and the decrease in Epo levels corroborate
our finding and suggest a diagnosis of an Epo-producing
granuloma. We speculate that a previously unknown
mechanism of Epo production must be operative in this tu-
bercle granuloma.
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